Privilège Ventures — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Enantiosenantios.comin𝕏Seed · Jun 2024 · $2M
Enantios provides structural measurement services for molecules and proteins, as well as selling ROA (Raman Optical Activity) instruments for molecular characterization.
BiotechDeep TechHardwareSwitzerland, CH
Roman Wyss(CEO Co-Founder)inMonika Dengler(CTO Co-Founder)in
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.